Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18090048 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C
Conditions: Hepatitis C, Chronic;   HIV CDC Category A1
Intervention: Drug: Sofosbuvir + Simeprevir
2 Recruiting HCV/HIV Coinfection: Antiviral Therapy and Fibrosis
Conditions: HIV Infection;   Hepatitis C
Intervention:

Indicates status has not been verified in more than two years